• 1
    Jonsson R, Bolstad AI, Brokstad KA et al. Sjögren's syndrome - a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007;1108:43347.
  • 2
    Theander E, Henriksson G, Ljungberg O et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796803.
  • 3
    Theander E, Vasaitis L, Baecklund E et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome. Ann Rheum Dis 2011;70:13638.
  • 4
    Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S et al. HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2012;11:2817.
  • 5
    Gottenberg JE, Busson M, Loiseau P et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003;48:22405.
  • 6
    Ice JA, Li H, Adrianto I et al. Genetics of Sjogren's syndrome in the genome-wide association era. J Autoimmun 2012;39:5763.
  • 7
    Korman BD, Alba MI, Le JM et al. Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun 2008;9:26770.
  • 8
    Miceli-Richard C, Comets E, Loiseau P et al. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis Rheum 2007;56:398994.
  • 9
    Nordmark G, Kristjansdottir G, Theander E et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun 2009;10:6876.
  • 10
    Shembade N, Ma A, Harhaj EW. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010;327:11359.
  • 11
    Ramirez VP, Gurevich I, Aneskievich BJ. Emerging roles for TNIP1 in regulating post-receptor signaling. Cytokine Growth Factor Rev 2012;23:10918.
  • 12
    Sankar S, Chan H, Romanow WJ et al. IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines. Cell Signal 2006;18:98293.
  • 13
    Graham RR, Cotsapas C, Davies L et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008;40:105961.
  • 14
    Musone SL, Taylor KE, Lu TT et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet 2008;40:10624.
  • 15
    Musone SL, Taylor KE, Nititham J et al. Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. Genes Immun 2011;12:17682.
  • 16
    Dieude P, Guedj M, Wipff J et al. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis 2010;69:195864.
  • 17
    Thomson W, Barton A, Ke X et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007;39:14313.
  • 18
    Nair RP, Duffin KC, Helms C et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009;41:199204.
  • 19
    Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:66178.
  • 20
    Allanore Y, Saad M, Dieude P et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011;7:e1002091.
  • 21
    Fung EY, Smyth DJ, Howson JM et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009;10:18891.
  • 22
    Gateva V, Sandling JK, Hom G et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009;41:122833.
  • 23
    Sun F, Li P, Chen H et al. Association studies of TNFSF4, TNFAIP3 and FAM167A-BLK polymorphisms with primary Sjogren's syndrome in Han Chinese. J Hum Genet 2013;58:4759.
  • 24
    Nordmark G, Kristjansdottir G, Theander E et al. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 2011;12:1009.
  • 25
    Dieguez-Gonzalez R, Akar S, Calaza M et al. Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis. Ann Rheum Dis 2009;68:57983.
  • 26
    Sandling JK, Garnier S, Sigurdsson S et al. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur J Hum Genet 2011;19:47984.
  • 27
    Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:5548.
  • 28
    Plenge RM, Seielstad M, Padyukov L et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007;357:1199209.
  • 29
    Ng WF, Bowman SJ, Griffiths B et al. United Kingdom Primary Sjogren's Syndrome Registry–a united effort to tackle an orphan rheumatic disease. Rheumatology (Oxford) 2011;50:329.
  • 30
    Fan JB, Oliphant A, Shen R et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 2003;68:6978.
  • 31
    Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009;5:e1000529.
  • 32
    Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:55975.
  • 33
    Adrianto I, Wang S, Wiley GB et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 2012;64:3695705.
  • 34
    Kawasaki A, Ito S, Furukawa H et al. Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: a case-control association study. Arthritis Res Ther 2010;12:R174.
  • 35
    Wang C, Ahlford A, Jarvinen TM et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet 2013;21:9949.
  • 36
    Zhong H, Li XL, Li M et al. Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 2011;13:R186.
  • 37
    Manoussakis MN, Georgopoulou C, Zintzaras E et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004;50:88291.
  • 38
    Lisi S, Sisto M, Lofrumento DD et al. Sjogren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-kappaB. Lab Invest 2012;92:61524.
  • 39
    Gallagher J, Howlin J, McCarthy C et al. Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett 2003;551:812.
  • 40
    Reksten TR, Johnsen SJ, Jonsson MV et al. Genetic associations to germinal centre formation in primary Sjogren's syndrome. Ann Rheum Dis 2013. doi: 10.1136/annrheumdis-2012-202500. [Epub ahead of print]
  • 41
    Cerhan JR, Liu-Mares W, Fredericksen ZS et al. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2008;17:31619.
  • 42
    Ungerbäck J, Belenki D, Jawad ul-Hassan A et al. Genetic variation and alterations of genes involved in NFkappaB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis 2012;33:212634.
  • 43
    Zou YF, Wang F, Feng XL et al. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Tissue Antigens 2011;77:917.
  • 44
    Salim PH, Jobim M, Bredemeier M et al. Interleukin-10 Gene Promoter and NFKB1 Promoter Insertion/Deletion Polymorphisms in Systemic Sclerosis. Scand J Immunol 2013;77:1628.
  • 45
    Honma K, Tsuzuki S, Nakagawa M et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009;114:246775.
  • 46
    Dong G, Chanudet E, Zeng N et al. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma. Clin Cancer Res 2011;17:144051.
  • 47
    Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006;7:78191.
  • 48
    Lavoie TN, Stewart CM, Berg KM et al. Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters. Scand J Immunol 2011;74:37782.
  • 49
    Rusakiewicz S, Nocturne G, Lazure T et al. NCR3/NKp30 contributes to pathogenesis in primary Sjögren's syndrome. Sci Transl Med 2013;5:19596.